Ocumension Therapeutics (HK:1477) has released an update.
Ocumension Therapeutics has announced that all proposed resolutions were approved by shareholders during its Annual General Meeting on June 20, 2024. Key resolutions included the adoption of the audited financial statements, re-election of board directors, and approval of general mandates for share allotment and repurchase. The meeting, marking a unified shareholder confidence, was held in Shanghai with a strong backing for all directorial and financial decisions.
For further insights into HK:1477 stock, check out TipRanks’ Stock Analysis page.
